Three months after discharge | Six months after discharge | |||||
Control group (N=52) | Treated group (N=66) | P value* | Control group (N=45) | Treated group (N=54) | P value* | |
mMRC score† (0–4) | 1.0 (0.0–2.0) | 1.0 (0.0–2.0) | 0.045 | |||
HADS anxiety† (0–21) | 3.0 (0.0–8.0) | 4.0 (1.0–9.0) | 0.455 | |||
HADS anxiety ≥8 | 26 | 31 | 0.603 | |||
HADS depression† (0–21) | 3.0 (1.0–8.0) | 4.0 (1.0–8.0) | 0.811 | |||
HADS depression ≥8 | 30 | 27 | 0.740 | |||
TSQ† (0–10) | 1.0 (0.0–2.5) | 1.0 (0.0–4.5) | 0.700 | |||
TSQ ≥6 | 8 | 24 | 0.056 | |||
EQ VAS (0–100) | 65.0 (57.5–75.0) | 70.0 (60.0–80.0) | 0.063 | 75.0 (60.0–80.0) | 75.0 (65.0–80.0) | 0.964 |
EQ VAS % of predicted population norm | 81 | 90 | 0.069 | 90 | 91 | 0.943 |
EQ-5D index (0–1) | 0.78 (0.69–0.86) | 0.86 (0.69–0.86) | 0.141 | 0.85 (0.78–1.00) | 0.89 (0.78–1.00) | 0.228 |
EQ-5D index % of predicted population norm | 86 | 92 | 0.036 | 93 | 97 | 0.354 |
Data are presented as % or median (IQR).
The mMRC was completed at 3 months after discharge by 51 control patients and 60 treated patients. The HADS was completed at 3 months after discharge by 50 control patients and 59 treated patients. The TSQ was completed at 3 months after discharge by 37 control patients and 46 treated patients. EQ VAS was completed by 33 control patients and 43 treated patients at 3 months and by 38 control patients and 46 treated patients at 6 months, respectively. EQ-5D index was completed by 53 control patients and 45 treated patients at 3 months and by 40 control patients and 47 treated patients at 6 months, respectively.
*P value of difference between the two groups, calculated by Mann-Whitney U test or χ2, as appropriate.
†Only measured at 3 months after hospital discharge.
EQ-5D, EuroQol 5-dimensions; EQ VAS, EuroQol Visual Analogue Scale; HADS, Hospital Anxiety and Depression Scale; mMRC, modified Medical Research Council; TSQ, Trauma Screening Questionnaire.